Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is FONDAPARINUX SODIUM, with a corresponding US DMF Number 34828.
Remarkably, this DMF maintains an Active status since its submission on April 29, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 09, 2020, and payment made on May 19, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II